HIGHLIGHTS
- who: . and collaborators from the Xinxiang Medical University, China have published the article: Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions, in the Journal: (JOURNAL) of 22/01/2023
- what: To give information for therapeutic practices, the aim of this study was to systematically evaluate the efficacy of ezetimibe for coronary atherosclerotic plaque compositions. Since the endpoints were not published in the original publication as a mean u00b1 standard deviation (mean u00b1 SD), the authors converted data using the approach described by Luo et_al . Future research studies on the effectiveness . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.